Nigeria’s Pharmacy Council said on Friday that its enforcement team had sealed 381 pharmacies and patent stores in Akwa Ibom for various crimes.
The director and head of the Enforcement Department, Stephen Esumobi, made the announcement during a briefing to journalists in Uyo, the state capital.
He said most of the affected stores had been sealed for violations such as operating without registering or renewing company certificates, unauthorized drug sales and poor access control to the poison cabinet.
Other violations included poor storage facilities and temperature control, stocking and sale of prescriptions and other ethical products by the patent drug vendors.
He said that following the council’s current efforts to streamline the drug distribution system, the enforcement team visited 727 premises, comprising 559 patent drug stores and 168 pharmacies.
Esumobi said: “The PCN enforcement team has been in Akwa Ibom State since the beginning of the week as a continuation of the municipality’s current efforts to streamline the drug distribution system in the country.
“The team visited the following local government areas; Uyo and its surroundings, Ikono, Abak, Itu, Eket, Ibesikpo/Asutan, Ikot Ekpene and Oron. At the end of the exercise. At the end of the exercise, a total of 727 premises were visited. This includes 559 patent drug stores and 168 pharmacies.
“In total, 381 premises were sealed, including 52 pharmacies and 329 patent drug stores. In total, 16 compliance guidelines have been issued.
“All registered premises are expected to display their current pledge certificates or proof of registration conspicuously in the premises so that members of the public know the status of premises where they purchase their medicines.
“The pledge certificates must be renewed on or before January 31 each year and it is an offense for any property to operate without registering or renewing their pledge certificates.
“In enforcing PCN laws, the main areas of focus for the PCN Enforcement Team are premises, personnel and practice. It is an offense for any interested party to operate a pharmaceutical business in a location not approved by PCN.”